The Advisory Board supports the implementation of UAEM’s overarching mission and provides expertise for our projects. The advisors are internationally renowned experts on access and innovation in global public health, several with specialised knowledge of patenting and licensing policies connected to university and publicly funded research.
Professor Benkler’s research at Harvard Law School explores the central role of information commons to innovation. On the heels of its successful campaign to extend access to a critical HIV-AIDS drug, Benkler guided UAEM in pioneering an open-licensing approach to increase access to university innovations and drafting model humanitarian licensing terms. His books include The Wealth of Networks: How Social Production Transforms Markets and Freedom (Yale University Press 2006).
Dr. Paul Farmer
Renowned doctor and anthropologist from Harvard Medical School, Dr. Farmer is the founder of Partners in Health, an international charity that provides direct health care services to some of the world’s most impoverished communities. Through pioneering novel, community-based treatment strategies for AIDS and tuberculosis, Dr. Farmer successfully challenged the policymakers and critics who claim that quality health care is impossible to deliver in resource-poor settings. Dr. Farmer has won multiple honors, including the Duke University Humanitarian Award and the MacArthur Foundation “genius award.” Dr. Farmer is also the subject of Pulitzer Prizewinner Tracy Kidder’s Mountains Beyond Mountains: The Quest of Dr. Paul Farmer, a Man Who Would Cure the World (Random House, 2003).
Ellen ‘t Hoen
As Director of Policy Advocacy of Médecins Sans Frontières’s Campaign for Access to Essential Medicines ’t Hoen works to promote affordable medicines prices and to stimulate health needs driven research and development since 1999. She was the founder of DES Action the Netherlands, previously directed Health Action International’s policy and campaigns unit, and was the international coordinator at the independent French journal La Revue Prescrire. In 2005 and 2006 she was listed as one of the 50 most influential people in intellectual property in the world by the journal ‘Managing Intellectual Property’. She has a Masters Degree in Law.
Amy Kapczynski is now Professor of Law at Yale Law School and also Co-Director of the Global Health Justice Partnerships as well as the Collaboration of Research Integrity and Transparency. She was previously an Assistant Professor of Law at the University of California at Berkeley Law School. Her research focuses on intellectual property law, international law, and global health issues. Amy received her J.D. from Yale Law School, and clerked for the U.S. Supreme Court (for Justices O’Connor and Breyer, 2005-06) and the United States Court of Appeals for the Second Circuit (for Judge Guido Calabresi, 2003-04). She served as a post-doctoral fellow at the Yale Law School and the Yale School of Public Health (2004-2005; 2006-2007). While at Yale Law School, Kapczynski helped lead efforts that resulted in Yale University and Bristol-Myers Squibb permitting generic competition and providing steep price discounts for an important anti-AIDS drug (d4T) in South Africa. Drawing on this experience, Kapczynski co-founded Universities Allied for Essential Medicines with other students in 2002.
Sir John Sulston
As Director of one of the world’s top sequencing centers – the Sanger Centre (UK) – Sulston played a leading role in the Human Genome Project and was a critical voice against patenting of human genetic information. In The Common Thread: A Story of Science, Politics, Ethics and the Human Genome, Sulston and his co-author argued that the information in the genome should be freely available for the benefit of all. Sulston is a Nobel Laureate in Medicine, a Fellow of the Royal Society, and an honorary fellow of Pembroke College, Cambridge.
As Director of the Program on Global Health and Technology Access at Duke University’s Terry Sanford Institute of Public Policy, So focuses on issues of globalization and health, particularly innovation and access to essential medicines for those in developing countries. Previously he served as Associate Director of the Rockefeller Foundation’s Health Equity program, where he helped to shape the Foundation’s work on access to medicines in developing countries and co-founded a cross-thematic program on charting a fairer course for intellectual property rights. Prior to joining the Foundation, Dr. So directed the activities of the Liaison Office for Quality (1997-98) as Senior Advisor to the Administrator at the Agency for Health Care Policy and Research, U.S. Department of Health and Human Services (DHHS).
Dr. Warren Ilchman received a BA from Brown and a PhD from Cambridge University. He has taught at Williams, Harvard, and Berkeley and was the dean of liberal arts at Boston University and executive vice president, SUNY at Albany. Later he served as president of Pratt Institute and was director of the Indiana University Center on Philanthropy. From 1998 to 2011, he served as the Executive Director of the Paul & Daisy Soros Fellowships for New Americans, a graduate support program for immigrants and the children of immigrants. He oversaw the appointment of more than 400 Soros Fellows. Dr. Warren also served as a consultant to many countries, foundations and international agencies including the Government of India, Nepal, and China; the Rockefeller Foundation, the Ford Foundation, the Thomas J. Watson Foundation, the World Bank, USAID, the National Endowment Humanities and the Department of Education.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.